Search

Cambridge Urban Forest Management Recommendations

A proposal for Climate Resilience is available for review

Learn more about how Cambridge participates in transit planning and the MBTA.

STEAM resources for adults to build new skills and access opportunities in the new innovation economy.

This multifaceted, multicultural event makes science accessible, interactive and fun, highlighting the impact of STEAM in all our lives.

Today (August 23, 2021), the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.

Today (January 31, 2022), the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older.

A summary of the many ways that parks and open space can be activated through programming and design.

Learn about how the city of Cambridge tracks greenhouse gas emissions.

Information about the Cambridge Water Department's source water quality monitoring program.